Picture of Abbisko Cayman logo

2256 Abbisko Cayman News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Abbisko Cayman Says Unit Obtained Clinical Trial Approval For Absk121

Feb 22 (Reuters) - Abbisko Cayman  2256.HK :
    * UNIT HAS OBTAINED CLINICAL TRIAL APPROVAL FROM NATIONAL
MEDICAL
PRODUCTS ADMINISTRATION FOR ABSK121

Further company coverage:  2256.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Abbisko Cayman

See all news